Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Delea

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Use of surrogate measures in cost-effectiveness analyses of lipid-lowering therapiesT E Delea
Drug Intelligence & Clinical Pharmacy|May 1, 1988
Comment: cost-effectiveness methodologyG Oster, T E Delea
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureT E Delea, J Karnon, P E Goss
American Journal of Preventive Medicine|July 1, 1988
Maternal smoking during pregnancy and expenditures on neonatal health careG Oster, T E Delea, G A Colditz
Current Oncology (Toronto, Ont.)|January 4, 2020
Preferences of Canadian patients and physicians for adjuvant treatments for melanomaD Stellato, M Thabane, C Eichten, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2012
Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastasesM Hagiwara, T E Delea, M W Saville, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in CanadaT E Delea, J Amdahl, A Chit, et al.
JAMA|September 12, 1986
Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smokingG Oster, D M Huse, T E Delea, et al.
Lancet (London, England)|August 22, 1987
Nicotine chewing-gumG A Colditz, D M Huse, T E Delea, et al.
Sexually Transmitted Diseases|September 1, 1996
The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteriaM C Dickerson, J Johnston, T E Delea, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Use of surrogate measures in cost-effectiveness analyses of lipid-lowering therapiesT E Delea
Drug Intelligence & Clinical Pharmacy|May 1, 1988
Comment: cost-effectiveness methodologyG Oster, T E Delea
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureT E Delea, J Karnon, P E Goss
American Journal of Preventive Medicine|July 1, 1988
Maternal smoking during pregnancy and expenditures on neonatal health careG Oster, T E Delea, G A Colditz
Current Oncology (Toronto, Ont.)|January 4, 2020
Preferences of Canadian patients and physicians for adjuvant treatments for melanomaD Stellato, M Thabane, C Eichten, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2012
Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastasesM Hagiwara, T E Delea, M W Saville, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in CanadaT E Delea, J Amdahl, A Chit, et al.
JAMA|September 12, 1986
Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smokingG Oster, D M Huse, T E Delea, et al.
Lancet (London, England)|August 22, 1987
Nicotine chewing-gumG A Colditz, D M Huse, T E Delea, et al.
Sexually Transmitted Diseases|September 1, 1996
The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteriaM C Dickerson, J Johnston, T E Delea, et al.
Pageof 2